TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28865902

Group type: EXPERIMENTAL
Intervention: Immediate auditory feedback
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Delayed auditory feedback
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Delayed visual feedback
Number of subjects: 69
Study: 26406293

Group type: EXPERIMENTAL
Intervention: Low AMH (<1.00 ng/mL, n = 124)
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Normal AMH (1.00-3.5 ng/mL, n = 595)
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: High AMH (>3.5 ng/mL, n = 483)
Number of subjects: 1202
Study: 23791606

Group type: EXPERIMENTAL
Intervention: Unilateral nerve block for routine dental procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical anesthetic cream
Number of subjects: 0
Study: 21540233

Group type: EXPERIMENTAL
Intervention: sRAGE levels (fifth compared with first quintile)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: CML-AGE levels (fifth compared with first quintile)
Number of subjects: 255
Study: 18521616

Group type: EXPERIMENTAL
Intervention: Mobile bearing high flex TKA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fixed bearing posterior stabilized TKA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 16961168

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (180 - 2160 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (not specified dosage)
Number of subjects: 0
Study: 15666026

Group type: EXPERIMENTAL
Intervention: Hysterosonography
Number of subjects: 50
Study: 11759868

Group type: EXPERIMENTAL
Intervention: Experimental fixture placed in a fresh extraction socket (TI)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Contralateral fixture in mature bone (CI)
Number of subjects: 48
Study: 15625835

Group type: EXPERIMENTAL
Intervention: Holothuria Ldeucospilota Acidic Mucopolysaccharide (HLAM) 60 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Holothuria Ldeucospilota Acidic Mucopolysaccharide (HLAM) 120 mg/d
Number of subjects: 0
Study: 8116326

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Methohexitone
Number of subjects: 40
Study: 3320844

Group type: EXPERIMENTAL
Intervention: Periapical instrumentation
Number of subjects: 106

Group type: COMPARATOR
Intervention: Intracanal instrumentation
Number of subjects: 106
Study: 31172211

Group type: EXPERIMENTAL
Intervention: Peripheral hypervascularity of the corpus luteum on ultrasound (Doppler US)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Peripheral hypervascularity of the corpus luteum on CT (CECT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: No peripheral hypervascularity of the corpus luteum
Number of subjects: 69

Group type: COMPARATOR
Intervention: Size of torsed ovaries
Number of subjects: 69
Study: 28449051

Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cobicistat-boosted elvitegravir (EVGcobi)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ritonavir-boosted darunavir (DRVrtv)
Number of subjects: 60
Study: 25317575

Group type: EXPERIMENTAL
Intervention: Mask A (Quattro®)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Mask B (Amara®)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Mask C (Forma®)
Number of subjects: 17
Study: 23296097

Group type: EXPERIMENTAL
Intervention: Tacrolimus modified-release once-daily preparation (Advagraf, Graceptor)
Number of subjects: 43
Study: 21459255

Group type: EXPERIMENTAL
Intervention: Video Doctor counseling
Number of subjects: 321

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 321
Study: 18268150

Group type: EXPERIMENTAL
Intervention: Postconditioning (repeated inflation and deflation of the angioplasty balloon)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 16537980

Group type: EXPERIMENTAL
Intervention: Leg-segmental method
Number of subjects: 100

Group type: COMPARATOR
Intervention: Global method
Number of subjects: 100
Study: 14723748

Group type: EXPERIMENTAL
Intervention: ONO‐8815Ly at 4 microg/minute
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ONO‐8815Ly at 8 microg/minute
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 11725927

Group type: EXPERIMENTAL
Intervention: Simes‐Hommel intersection‐union tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resampling‐Based methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bonferroni‐Holm
Number of subjects: 0
Study: 10322833

Group type: EXPERIMENTAL
Intervention: Supplemented Sini San (SSNS)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Dioscorea Nipponica Power (Control)
Number of subjects: 127
Study: 8489354

Group type: EXPERIMENTAL
Intervention: Training Group (TG)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 66
Study: 2942806

Group type: EXPERIMENTAL
Intervention: Fenoterol/ipratropium combination (100 micrograms fenoterol and 40 micrograms ipratropium bromide per puff, 2 puffs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Salbutamol (100 micrograms per puff, 2 puffs)
Number of subjects: 10
Study: 27458105

Group type: EXPERIMENTAL
Intervention: Endotoxin (0.6 ng/kg)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 28007133

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg once daily for 5 years
Number of subjects: 3318

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3318
Study: 25876338

Group type: EXPERIMENTAL
Intervention: Combined therapy of acupuncture and tapping method
Number of subjects: 104

Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 104
Study: 21557265

Group type: EXPERIMENTAL
Intervention: Asenapine (ASE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-desmethylasenapine (DMA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 11-O-sulfate-asenapine (OSA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asenapine-N(+) -glucuronide (ASG)
Number of subjects: 0
Study: 20536517

Group type: EXPERIMENTAL
Intervention: Diabetes Care Protocol (DCP)
Number of subjects: 3389

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 3389
Study: 19856616

Group type: EXPERIMENTAL
Intervention: Web site plus peer-led support group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Web site only
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Web site only and Web site plus peer-led support group
Number of subjects: 21
Study: 12166461

Group type: EXPERIMENTAL
Intervention: Randomized clinical trial (RCT)
Number of subjects: 0
Study: 9581367

Group type: EXPERIMENTAL
Intervention: Spiral vented titanium post
Number of subjects: 30

Group type: COMPARATOR
Intervention: Spiral serrated, hollow stainless steel post
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Spiral hollow stainless steel post
Number of subjects: 30
Study: 8139605

Group type: EXPERIMENTAL
Intervention: Complete vision
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vision of the target occluded
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No vision of the moving hand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No visual feedback (both target and hand occluded)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual feedback (any condition)
Number of subjects: 0
Study: 3293872

Group type: EXPERIMENTAL
Intervention: Tyramine administered by bolus injection
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tyramine administered by infusion
Number of subjects: 12
Study: 31935778

Group type: EXPERIMENTAL
Intervention: Eccentric training program (15 sessions of four eccentric exercises)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study: 31445956

Group type: EXPERIMENTAL
Intervention: 30 Gy in 1 fraction (arm 1)
Number of subjects: 98

Group type: COMPARATOR
Intervention: 60 Gy in 3 fractions (arm 2)
Number of subjects: 98
Study: 28220486

Group type: EXPERIMENTAL
Intervention: Cetuximab plus irinotecan (Cmab + I)
Number of subjects: 1081

Group type: COMPARATOR
Intervention: Panitumumab (Pmab)
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 1081
Study: 25332252

Group type: EXPERIMENTAL
Intervention: PAM50-based risk of recurrence (ROR) score
Number of subjects: 2137

Group type: EXPERIMENTAL
Intervention: Clinical Treatment Score (CTS)
Number of subjects: 2137
Study: 23758078

Group type: EXPERIMENTAL
Intervention: Usual care plus weekly/biweekly teleconsultations with an endocrinologist (n=12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Usual care (control; n=11)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Usual care plus teleconsultations (n=12)
Number of subjects: 23
Study: 21478777

Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioral therapy (CBT) plus pedometer-based walking program
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 291
Study: 18855558

Group type: EXPERIMENTAL
Intervention: Nonadjuvanted RSV vaccine
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Adjuvanted RSV vaccine
Number of subjects: 1169

Group type: COMPARATOR
Intervention: RSV vaccine (both formulations)
Number of subjects: 1169

Group type: COMPARATOR
Intervention: Influenza vaccine
Number of subjects: 1169
Study: 16861098

Group type: EXPERIMENTAL
Intervention: Propacetamol 30 mg/kg IV
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 12911355

Group type: EXPERIMENTAL
Intervention: Single-use bougie
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oral flexible intubating fibrescope
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 64
Study: 10787581

Group type: EXPERIMENTAL
Intervention: Process variables in primary care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Process variables in secondary care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient outcomes in primary care
Number of subjects: 0
Study: 9233368

Group type: EXPERIMENTAL
Intervention: Faded bedtime with response cost (FBRC)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Bedtime scheduling procedure
Number of subjects: 2
Study: 8130009

Group type: EXPERIMENTAL
Intervention: Low-molecular-heparin (Sandoparin)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard-heparin (Liquemin: 3 x 5000 I.E.)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard-heparin
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low-molecular-heparin
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Liquid Crystal Contact Thermography (LCCT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Ultrasound examination
Number of subjects: 68
Study: 30239830

Group type: EXPERIMENTAL
Intervention: Monovalent type 3 OPV
Number of subjects: 240
Study: 29560311

Group type: EXPERIMENTAL
Intervention: 100 μg LSD
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 26371766

Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Long pulsed Nd:YAG laser
Number of subjects: 22
Study: 24128648

Group type: EXPERIMENTAL
Intervention: Infecting strain from cases
Number of subjects: 163

Group type: COMPARATOR
Intervention: Household contacts with colonizing strain
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Overall strain types identified
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Intrafamilial strain-relatedness
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Cases with discordant strains
Number of subjects: 163
Study: 22362335

Group type: EXPERIMENTAL
Intervention: Rest SPECT MPI
Number of subjects: 294
Study: 20117912

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine 0.1 mg (group M)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 66
Study: 17936643

Group type: EXPERIMENTAL
Intervention: 100 mg caffeine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 16918590

Group type: EXPERIMENTAL
Intervention: Ghrelin (1 microg/kg, intravenously)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ghrelin plus GHRH (1 microg/kg, iv)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 12848832

Group type: EXPERIMENTAL
Intervention: Workbook-Journal (WBJ) intervention plus educational materials
Number of subjects: 100

Group type: COMPARATOR
Intervention: Educational materials alone (usual care)
Number of subjects: 100
Study: 11149624

Group type: EXPERIMENTAL
Intervention: Insulin infusion (1.5 mU/kg x min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo infusion (saline solution)
Number of subjects: 50
Study: 8637693

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry with sterile disposable silicone tonometer shield
Number of subjects: 120

Group type: COMPARATOR
Intervention: Goldmann applanation tonometry without shield (uncovered)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry with silicone shield
Number of subjects: 120
Study: 1483552

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg/day
Number of subjects: 399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study: 4048899

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Magaldrate tablets
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Al-Mg-hydroxide tablets
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo liquid
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Magaldrate liquid
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Al-Mg-hydroxide liquid
Number of subjects: 9
Study: 30041895

Group type: EXPERIMENTAL
Intervention: Ergonomic adjustment and physiotherapy program (using ErgoDis/IBV software) for twelve weeks, two 60-min sessions per week
Number of subjects: 8
Study: 30104421

Group type: EXPERIMENTAL
Intervention: Nurse home visit after standard pediatric discharge
Number of subjects: 1372
Study: 27063928

Group type: EXPERIMENTAL
Intervention: AZP-531 15 µg/kg or higher
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: AZP-531
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: AZP-531 60 µg/kg
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 24866968

Group type: EXPERIMENTAL
Intervention: Dynamic supportive‐expressive therapy
Number of subjects: 134

Group type: COMPARATOR
Intervention: Supportive clinical management combined with pharmacotherapy or placebo
Number of subjects: 134
Study: 23135193

Group type: EXPERIMENTAL
Intervention: 1 week of rapid expansion followed by maxillary protraction (group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5 weeks of repetitive rapid expansion and constriction followed by maxillary protraction (group B)
Number of subjects: 20
Study: 20822968

Group type: EXPERIMENTAL
Intervention: 50 µg/m³ elemental carbon UFP for 2 hr
Number of subjects: 19

Group type: COMPARATOR
Intervention: Filtered air
Number of subjects: 19
Study: 17937474

Group type: EXPERIMENTAL
Intervention: Infliximab (3 to 10 mg/kg) plus methotrexate (MTX)
Number of subjects: 2495

Group type: COMPARATOR
Intervention: MTX plus placebo
Number of subjects: 2495
Study: 15848713

Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 3209

Group type: COMPARATOR
Intervention: No induction
Number of subjects: 3209
Study: 11931675

Group type: EXPERIMENTAL
Intervention: OCD group
Number of subjects: 34

Group type: COMPARATOR
Intervention: NA control group
Number of subjects: 34

Group type: COMPARATOR
Intervention: GAD group
Number of subjects: 34
Study: 9767748

Group type: EXPERIMENTAL
Intervention: Spectra Leukoreduction System (LRS)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard plateletpheresis procedures (control)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: LRS
Number of subjects: 115
Study: 7610357

Group type: EXPERIMENTAL
Intervention: Pancreatic extract (Pancrex-Duo capsules, 34,375 USP units of protease, 4 capsules four times daily for 4 months)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (4 capsules four times daily for 4 months)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pancreatic extract and placebo (second 4 months of follow-up)
Number of subjects: 26
Study: 2118307

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) 320/1,600 mg daily
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) 160/800 mg daily
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 215307

Group type: EXPERIMENTAL
Intervention: Thymosin at a dose of 60 mg/m2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thymosin at a dose of 20 mg/m2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31133127

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (milk and eggs)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Control (basic food allowance)
Number of subjects: 336
Study: 28618724

Group type: EXPERIMENTAL
Intervention: Vitamin E (400 mg/BD/IM)
Number of subjects: 0
Study: 24441390

Group type: EXPERIMENTAL
Intervention: Aortic valve sclerosis (AVS)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Culprit lesion Syntax score (SX score)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Symptom-to-balloon time
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Male gender, smoking, hypertension
Number of subjects: 41
Study: 23588235

Group type: EXPERIMENTAL
Intervention: Lactulose 25 g
Number of subjects: 43
Study: 21810024

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Insulin detemir
Number of subjects: 88
Study: 19513632

Group type: EXPERIMENTAL
Intervention: Once daily (o.d.) dosing of insulin detemir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twice daily (b.i.d.) dosing of insulin detemir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Switching from o.d. to b.i.d. dosing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin dose
Number of subjects: 0
Study: 16426286

Group type: EXPERIMENTAL
Intervention: Barrier cream containing vaseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Barrier cream containing bees wax
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Barrier cream containing waxes and surfactant
Number of subjects: 0

Group type: COMPARATOR
Intervention: No barrier cream (control)
Number of subjects: 0
Study: 12877903

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg/day for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10764367

Group type: EXPERIMENTAL
Intervention: Nurse Practitioner consultations
Number of subjects: 1292

Group type: COMPARATOR
Intervention: General Practitioner consultations
Number of subjects: 1292
Study: 8818851

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once daily for 3 days)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Co-amoxiclav (37 mg three times daily for 10 days)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 369

Group type: COMPARATOR
Intervention: Co-amoxiclav
Number of subjects: 369
Study: 1444727

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 4063589

Group type: EXPERIMENTAL
Intervention: Day hospital care
Number of subjects: 91

Group type: COMPARATOR
Intervention: In‐patient care
Number of subjects: 91
Study: 30957878

Group type: EXPERIMENTAL
Intervention: Violent cartoon
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Nonviolent cartoon
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Nonviolent cartoon (females)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Violent cartoon (males)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Mediation analysis
Number of subjects: 3000
Study: 29179601

Group type: EXPERIMENTAL
Intervention: Education based on health belief model (HBM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 28750695

Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg twice daily + low-dose aspirin (ASA)
Number of subjects: 21162

Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg twice daily + low-dose ASA
Number of subjects: 21162

Group type: COMPARATOR
Intervention: Placebo + low-dose aspirin (ASA)
Number of subjects: 21162
Study: 25968470

Group type: EXPERIMENTAL
Intervention: Endurance training (A)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Endurance strength training (B)
Number of subjects: 44
Study: 22645405

Group type: EXPERIMENTAL
Intervention: Integrated Palliative advanced homecare and heart Failure care (PREFER)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 21597401

Group type: EXPERIMENTAL
Intervention: Prophylactic peritoneal fenestration
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard surgical procedure without fenestration
Number of subjects: 130
Study: 19406232

Group type: EXPERIMENTAL
Intervention: Lyophilized orally disintegrating tablets (ODTs) of nimesulide (100mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional immediate release tablet (Sulide)
Number of subjects: 0
Study: 17003295

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 1513

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1513
Study: 15302082

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11134193

Group type: EXPERIMENTAL
Intervention: Doxorubicin (n = 637, median total dose of 294 mg/m(2))
Number of subjects: 1000

Group type: COMPARATOR
Intervention: CMF regimen (n = 363)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Doxorubicin-treated patients
Number of subjects: 1000

Group type: COMPARATOR
Intervention: CMF-treated patients
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Breast irradiation
Number of subjects: 1000